Neoadjuvant Chemotherapy in Cervical Carcinoma
Open Access
- 1 November 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (5) , 729-737
- https://doi.org/10.1309/8b4e-57pr-t50f-vrqt
Abstract
To evaluate whether cellular markers predict the responsiveness to neoadjuvant chemotherapy (NAC) in cervical cancer, 21 patients with stages I and IKeywords
This publication has 30 references indexed in Scilit:
- Concurrent chemotherapy and radiation for locally advanced cervical cancer: The new standard of careSeminars in Radiation Oncology, 2000
- Time to add chemotherapy to radiotherapy for cervical cancerThe Lancet, 1999
- Failure to Demonstrate Human Papillomavirus DNA in Epithelial Ovarian Cancer by General Primer PCRGynecologic Oncology, 1999
- CURRENT DEVELOPMENTS IN THE TREATMENT OF NEWLY DIAGNOSED CERVICAL CANCERHematology/Oncology Clinics of North America, 1999
- bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1999
- Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapyRadiotherapy and Oncology, 1999
- Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathwaysProceedings of the National Academy of Sciences, 1998
- Long-Term Follow-up of the First Randomized Trial Using Neoadjuvant Chemotherapy in Stage Ib Squamous Carcinoma of the Cervix: The Final ResultsGynecologic Oncology, 1997
- Strategies for global control of cervical cancerInternational Journal of Cancer, 1995
- Colposcopically directed punch biopsy: a potentially misleading investigationBJOG: An International Journal of Obstetrics and Gynaecology, 1991